Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.

Clement LC, Avila-Casado C, Macé C, Soria E, Bakker WW, Kersten S, Chugh SS.

Nat Med. 2011 Jan;17(1):117-22. doi: 10.1038/nm.2261. Epub 2010 Dec 12.

2.

New insights into human minimal change disease: lessons from animal models.

Chugh SS, Clement LC, Macé C.

Am J Kidney Dis. 2012 Feb;59(2):284-92. doi: 10.1053/j.ajkd.2011.07.024. Epub 2011 Oct 5. Review.

3.

Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.

Clement LC, Macé C, Avila-Casado C, Joles JA, Kersten S, Chugh SS.

Nat Med. 2014 Jan;20(1):37-46. doi: 10.1038/nm.3396. Epub 2013 Dec 8.

4.

Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease.

Li JS, Chen X, Peng L, Wei SY, Zhao SL, Diao TT, He YX, Liu F, Wei QJ, Zhang QF, Li B.

PLoS One. 2015 Sep 9;10(9):e0137049. doi: 10.1371/journal.pone.0137049. eCollection 2015.

5.

Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy.

Ma J, Chen X, Li JS, Peng L, Wei SY, Zhao SL, Li T, Zhu D, He YX, Wei QJ, Li B.

Endocrine. 2015 Jun;49(2):373-84. doi: 10.1007/s12020-014-0486-5. Epub 2014 Nov 26.

PMID:
25424436
6.

The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.

Peng L, Ma J, Cui R, Chen X, Wei SY, Wei QJ, Li B.

PLoS One. 2014 Aug 28;9(8):e106164. doi: 10.1371/journal.pone.0106164. eCollection 2014.

7.

Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics.

Macé C, Chugh SS.

J Am Soc Nephrol. 2014 Nov;25(11):2393-8. doi: 10.1681/ASN.2014030267. Epub 2014 May 22. Review.

8.

Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease.

Chugh SS, Macé C, Clement LC, Del Nogal Avila M, Marshall CB.

Front Pharmacol. 2014 Feb 25;5:23. doi: 10.3389/fphar.2014.00023. eCollection 2014. Review.

9.

The proteinuria-hypertriglyceridemia connection as a basis for novel therapeutics for nephrotic syndrome.

Clement LC, Macé C, Del Nogal Avila M, Marshall CB, Chugh SS.

Transl Res. 2015 Apr;165(4):499-504. doi: 10.1016/j.trsl.2014.06.004. Epub 2014 Jun 18. Review.

10.

[ManNAc, a new therapeutic agent to reduce Angptl4-induced proteinuria in MCD].

Clément L, Macé C.

Med Sci (Paris). 2016 Jun-Jul;32(6-7):606-11. doi: 10.1051/medsci/20163206024. Epub 2016 Jul 12. French.

PMID:
27406771
11.

Angiopoietin-like-4 and minimal change disease.

Cara-Fuentes G, Segarra A, Silva-Sanchez C, Wang H, Lanaspa MA, Johnson RJ, Garin EH.

PLoS One. 2017 Apr 25;12(4):e0176198. doi: 10.1371/journal.pone.0176198. eCollection 2017.

12.
13.

Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.

Agrawal V, Prasad N, Jain M, Pandey R.

Clin Exp Nephrol. 2013 Dec;17(6):811-8. doi: 10.1007/s10157-013-0775-y. Epub 2013 Feb 2.

PMID:
23377573
14.

HIV-associated nephropathy: experimental models.

Avila-Casado C, Fortoul TI, Chugh SS.

Contrib Nephrol. 2011;169:270-85. doi: 10.1159/000320212. Epub 2011 Jan 20.

PMID:
21252526
15.

Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase.

Kinugasa S, Tojo A, Sakai T, Tsumura H, Takahashi M, Hirata Y, Fujita T.

Kidney Int. 2011 Dec;80(12):1328-38. doi: 10.1038/ki.2011.282. Epub 2011 Aug 17.

16.

Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.

Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G.

Am J Kidney Dis. 1997 Sep;30(3):404-12.

PMID:
9292570
17.

[New insight in pathogenesis of podocyte disfunction in minimal change disease].

Liu S, Chen J.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 Mar;45(2):214-8. Chinese.

PMID:
27273997
18.

The glomerular permeability factors in idiopathic nephrotic syndrome.

Davin JC.

Pediatr Nephrol. 2016 Feb;31(2):207-15. doi: 10.1007/s00467-015-3082-x. Epub 2015 Apr 30. Review.

19.

A novel role of angiopoietin-like-3 associated with podocyte injury.

Liu J, Gao X, Zhai Y, Shen Q, Sun L, Feng C, Rao J, Liu H, Zha X, Guo M, Ma D, Zhang Z, Li R, Xu H.

Pediatr Res. 2015 Jun;77(6):732-9. doi: 10.1038/pr.2015.38. Epub 2015 Feb 24.

PMID:
25710887
20.

Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.

Carraro M, Caridi G, Bruschi M, Artero M, Bertelli R, Zennaro C, Musante L, Candiano G, Perfumo F, Ghiggeri GM.

J Am Soc Nephrol. 2002 Jul;13(7):1946-52.

Supplemental Content

Support Center